Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

The in vivo endothelial cell translatome is highly heterogeneous across vascular beds.

Cleuren ACA, van der Ent MA, Jiang H, Hunker KL, Yee A, Siemieniak DR, Molema G, Aird WC, Ganesh SK, Ginsburg D.

Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23618-23624. doi: 10.1073/pnas.1912409116. Epub 2019 Nov 11.

PMID:
31712416
2.

Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study.

Waksman R, Di Mario C, Torguson R, Ali ZA, Singh V, Skinner WH, Artis AK, Cate TT, Powers E, Kim C, Regar E, Wong SC, Lewis S, Wykrzykowska J, Dube S, Kazziha S, van der Ent M, Shah P, Craig PE, Zou Q, Kolm P, Brewer HB, Garcia-Garcia HM; LRP Investigators.

Lancet. 2019 Nov 2;394(10209):1629-1637. doi: 10.1016/S0140-6736(19)31794-5. Epub 2019 Sep 27. Erratum in: Lancet. 2019 Nov 2;394(10209):1618.

PMID:
31570255
3.

Endocrine Disorders Are Prominent Clinical Features in Patients With Primary Antibody Deficiencies.

Coopmans EC, Chunharojrith P, Neggers SJCMM, van der Ent MW, Swagemakers SMA, Hollink IH, Barendregt BH, van der Spek PJ, van der Lely AJ, van Hagen PM, Dalm VASH.

Front Immunol. 2019 Aug 30;10:2079. doi: 10.3389/fimmu.2019.02079. eCollection 2019.

4.

Loss of SMPD4 Causes a Developmental Disorder Characterized by Microcephaly and Congenital Arthrogryposis.

Magini P, Smits DJ, Vandervore L, Schot R, Columbaro M, Kasteleijn E, van der Ent M, Palombo F, Lequin MH, Dremmen M, de Wit MCY, Severino M, Divizia MT, Striano P, Ordonez-Herrera N, Alhashem A, Al Fares A, Al Ghamdi M, Rolfs A, Bauer P, Demmers J, Verheijen FW, Wilke M, van Slegtenhorst M, van der Spek PJ, Seri M, Jansen AC, Stottmann RW, Hufnagel RB, Hopkin RJ, Aljeaid D, Wiszniewski W, Gawlinski P, Laure-Kamionowska M, Alkuraya FS, Akleh H, Stanley V, Musaev D, Gleeson JG, Zaki MS, Brunetti-Pierri N, Cappuccio G, Davidov B, Basel-Salmon L, Bazak L, Shahar NR, Bertoli-Avella A, Mirzaa GM, Dobyns WB, Pippucci T, Fornerod M, Mancini GMS.

Am J Hum Genet. 2019 Oct 3;105(4):689-705. doi: 10.1016/j.ajhg.2019.08.006. Epub 2019 Sep 5.

PMID:
31495489
5.

Resolute zotarolimus-eluting stent in ST-elevation myocardial infarction (resolute-STEMI): A prespecified prospective register from the DAPT-STEMI trial.

Postma W, Fabris E, Van der Ent M, Hermanides R, Buszman P, Von Birgelen C C, Cook S, Wedel H, De Luca G, Delewi R, Zijlstra F, Kedhi E.

Catheter Cardiovasc Interv. 2019 Jul 3. doi: 10.1002/ccd.28376. [Epub ahead of print]

PMID:
31268629
6.

Abluminal biodegradable polymer biolimus-eluting versus durable polymer everolimus-eluting stent in patients with diabetes mellitus: 5 years follow-up from the COMPARE II trial.

Paradies V, Vlachojannis GJ, Royaards KJ, Wassing J, van der Ent M, Smits PC.

Int J Cardiol. 2019 Sep 1;290:40-44. doi: 10.1016/j.ijcard.2019.04.054. Epub 2019 May 3.

7.

Angiographic and Midterm Outcomes of Bioresorbable Vascular Scaffold for Coronary Bifurcation Lesions.

Paradies V, Vlachojannis GJ, Royaards KJ, Wassing J, van der Ent M, Smits PC.

Am J Cardiol. 2018 Dec 15;122(12):2035-2042. doi: 10.1016/j.amjcard.2018.09.003. Epub 2018 Sep 13.

PMID:
30360886
8.

Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial.

Kedhi E, Fabris E, van der Ent M, Buszman P, von Birgelen C, Roolvink V, Zurakowski A, Schotborgh CE, Hoorntje JCA, Eek CH, Cook S, Togni M, Meuwissen M, van Royen N, van Vliet R, Wedel H, Delewi R, Zijlstra F.

BMJ. 2018 Oct 2;363:k3793. doi: 10.1136/bmj.k3793.

9.

Long-term invasive follow-up of bioresorbable vascular scaffold: Optical Coherence Tomography assessment of jailed side branches.

Paradies V, Smits PC, Vachojannis GJ, Royaards KJ, Wassing J, van der Ent M.

Cardiovasc Revasc Med. 2018 Apr;19(3 Pt A):279-285. doi: 10.1016/j.carrev.2017.09.001. Epub 2017 Sep 10.

PMID:
29066339
10.

Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).

Vlachojannis GJ, Smits PC, Hofma SH, Togni M, Vázquez N, Valdés M, Voudris V, Slagboom T, Goy JJ, den Heijer P, van der Ent M.

JACC Cardiovasc Interv. 2017 Jun 26;10(12):1215-1221. doi: 10.1016/j.jcin.2017.02.029. Epub 2017 May 31.

11.

A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial".

Kedhi E, Fabris E, van der Ent M, Kennedy MW, Buszman P, von Birgelen C, Cook S, Wedel H, Zijlstra F.

Am Heart J. 2017 Jun;188:11-17. doi: 10.1016/j.ahj.2017.02.018. Epub 2017 Feb 20.

PMID:
28577666
12.

The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.

Astle WJ, Elding H, Jiang T, Allen D, Ruklisa D, Mann AL, Mead D, Bouman H, Riveros-Mckay F, Kostadima MA, Lambourne JJ, Sivapalaratnam S, Downes K, Kundu K, Bomba L, Berentsen K, Bradley JR, Daugherty LC, Delaneau O, Freson K, Garner SF, Grassi L, Guerrero J, Haimel M, Janssen-Megens EM, Kaan A, Kamat M, Kim B, Mandoli A, Marchini J, Martens JHA, Meacham S, Megy K, O'Connell J, Petersen R, Sharifi N, Sheard SM, Staley JR, Tuna S, van der Ent M, Walter K, Wang SY, Wheeler E, Wilder SP, Iotchkova V, Moore C, Sambrook J, Stunnenberg HG, Di Angelantonio E, Kaptoge S, Kuijpers TW, Carrillo-de-Santa-Pau E, Juan D, Rico D, Valencia A, Chen L, Ge B, Vasquez L, Kwan T, Garrido-Martín D, Watt S, Yang Y, Guigo R, Beck S, Paul DS, Pastinen T, Bujold D, Bourque G, Frontini M, Danesh J, Roberts DJ, Ouwehand WH, Butterworth AS, Soranzo N.

Cell. 2016 Nov 17;167(5):1415-1429.e19. doi: 10.1016/j.cell.2016.10.042.

13.
14.

Pressure-controlled intermittent coronary sinus occlusion (PICSO) in acute ST-segment elevation myocardial infarction: results of the Prepare RAMSES safety and feasibility study.

van de Hoef TP, Nijveldt R, van der Ent M, Neunteufl T, Meuwissen M, Khattab A, Berger R, Kuijt WJ, Wykrzykowska J, Tijssen JG, van Rossum AC, Stone GW, Piek JJ.

EuroIntervention. 2015 May;11(1):37-44. doi: 10.4244/EIJY15M03_10.

15.

Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity.

Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese F, Cheng SC, Ratter J, Berentsen K, van der Ent MA, Sharifi N, Janssen-Megens EM, Ter Huurne M, Mandoli A, van Schaik T, Ng A, Burden F, Downes K, Frontini M, Kumar V, Giamarellos-Bourboulis EJ, Ouwehand WH, van der Meer JW, Joosten LA, Wijmenga C, Martens JH, Xavier RJ, Logie C, Netea MG, Stunnenberg HG.

Science. 2014 Sep 26;345(6204):1251086. doi: 10.1126/science.1251086.

16.

Transcriptional diversity during lineage commitment of human blood progenitors.

Chen L, Kostadima M, Martens JHA, Canu G, Garcia SP, Turro E, Downes K, Macaulay IC, Bielczyk-Maczynska E, Coe S, Farrow S, Poudel P, Burden F, Jansen SBG, Astle WJ, Attwood A, Bariana T, de Bono B, Breschi A, Chambers JC, Consortium B, Choudry FA, Clarke L, Coupland P, van der Ent M, Erber WN, Jansen JH, Favier R, Fenech ME, Foad N, Freson K, van Geet C, Gomez K, Guigo R, Hampshire D, Kelly AM, Kerstens HHD, Kooner JS, Laffan M, Lentaigne C, Labalette C, Martin T, Meacham S, Mumford A, Nürnberg S, Palumbo E, van der Reijden BA, Richardson D, Sammut SJ, Slodkowicz G, Tamuri AU, Vasquez L, Voss K, Watt S, Westbury S, Flicek P, Loos R, Goldman N, Bertone P, Read RJ, Richardson S, Cvejic A, Soranzo N, Ouwehand WH, Stunnenberg HG, Frontini M, Rendon A.

Science. 2014 Sep 26;345(6204):1251033. doi: 10.1126/science.1251033.

17.

Conventional hemodynamic resuscitation may fail to optimize tissue perfusion: an observational study on the effects of dobutamine, enoximone, and norepinephrine in patients with acute myocardial infarction complicated by cardiogenic shock.

den Uil CA, Lagrand WK, van der Ent M, Nieman K, Struijs A, Jewbali LS, Constantinescu AA, Spronk PE, Simoons ML.

PLoS One. 2014 Aug 1;9(8):e103978. doi: 10.1371/journal.pone.0103978. eCollection 2014.

18.

A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade(®)) in exudative age-related macular degeneration.

van Hagen PM, Baarsma GS, van Bilsen CE, Kuijpers RW, van Laar JA, van der Ent M, van Daele PL, Veeger NJ, Vingerling JR, Missotten TO.

Acta Ophthalmol. 2014 Dec;92(8):e691-2. doi: 10.1111/aos.12471. Epub 2014 Jun 22. No abstract available.

19.

Serial optical frequency domain imaging in STEMI patients: the follow-up report of TROFI study.

García-García HM, Muramatsu T, Nakatani S, Lee IS, Holm NR, Thuesen L, van Geuns RJ, van der Ent M, Borovicanin V, Paunovic D, Onuma Y, Serruys PW.

Eur Heart J Cardiovasc Imaging. 2014 Sep;15(9):987-95. doi: 10.1093/ehjci/jeu042. Epub 2014 Mar 23.

PMID:
24662443
20.

Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner.

Kocatürk B, Van den Berg YW, Tieken C, Mieog JS, de Kruijf EM, Engels CC, van der Ent MA, Kuppen PJ, Van de Velde CJ, Ruf W, Reitsma PH, Osanto S, Liefers GJ, Bogdanov VY, Versteeg HH.

Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11517-22. doi: 10.1073/pnas.1307100110. Epub 2013 Jun 25.

21.

Randomized study to assess the effect of thrombus aspiration on flow area in patients with ST-elevation myocardial infarction: an optical frequency domain imaging study--TROFI trial.

Onuma Y, Thuesen L, van Geuns RJ, van der Ent M, Desch S, Fajadet J, Christiansen E, Smits P, Holm NR, Regar E, van Mieghem N, Borovicanin V, Paunovic D, Senshu K, van Es GA, Muramatsu T, Lee IS, Schuler G, Zijlstra F, Garcia-Garcia HM, Serruys PW; TROFI Investigators.

Eur Heart J. 2013 Apr;34(14):1050-60. doi: 10.1093/eurheartj/ehs456. Epub 2013 Feb 8.

PMID:
23396493
22.

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial.

Smits PC, Hofma S, Togni M, Vázquez N, Valdés M, Voudris V, Slagboom T, Goy JJ, Vuillomenet A, Serra A, Nouche RT, den Heijer P, van der Ent M.

Lancet. 2013 Feb 23;381(9867):651-60. doi: 10.1016/S0140-6736(12)61852-2. Epub 2013 Jan 30.

PMID:
23374650
23.

Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol vShield device for the treatment of IVUS and OCT-derived thin cap fibroatheromas (TCFAs) in native coronary arteries: report of the pilot study vShield Evaluated at Cardiac hospital in Rotterdam for Investigation and Treatment of TCFA (SECRITT).

Wykrzykowska JJ, Diletti R, Gutierrez-Chico JL, van Geuns RJ, van der Giessen WJ, Ramcharitar S, Duckers HE, Schultz C, de Feyter P, van der Ent M, Regar E, de Jaegere P, Garcia-Garcia HM, Pawar R, Gonzalo N, Ligthart J, de Schepper J, van den Berg N, Milewski K, Granada JF, Serruys PW.

EuroIntervention. 2012 Dec 20;8(8):945-54. doi: 10.4244/EIJV8I8A144.

24.

PAX3-FOXO1 and FGFR4 in alveolar rhabdomyosarcoma.

Marshall AD, van der Ent MA, Grosveld GC.

Mol Carcinog. 2012 Oct;51(10):807-15. doi: 10.1002/mc.20848. Epub 2011 Aug 31.

PMID:
21882254
25.

CRosser As First choice for crossing Totally occluded coronary arteries (CRAFT Registry): focus on conventional angiography and computed tomography angiography predictors of success.

García-García HM, Brugaletta S, van Mieghem CA, Gonzalo N, Diletti R, Gomez-Lara J, Airoldi F, Carlino M, Tavano D, Chieffo A, Montorfano M, Michev I, Colombo A, van der Ent M, Serruys PW.

EuroIntervention. 2011 Aug;7(4):480-6. doi: 10.4244/EIJV7I4A78.

26.

Encouraging survival rates in patients with acute myocardial infarction treated with an intra-aortic balloon pump.

Valk SD, Cheng JM, den Uil CA, Lagrand WK, van der Ent M, van de Sande M, van Domburg RT, Simoons ML.

Neth Heart J. 2011 Mar;19(3):112-118. Epub 2011 Jan 18.

27.

The feasibility and safety of applying the Magnetic Navigation System to manage chronically occluded vessels: a single centre experience.

Ramcharitar S, van der Giessen WJ, van der Ent M, de Feyter P, Serruys PW, van Geuns RJ.

EuroIntervention. 2011 Jan;6(6):711-6. doi: 10.4244/A120.

PMID:
21205593
28.

Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock.

den Uil CA, Lagrand WK, van der Ent M, Jewbali LS, Cheng JM, Spronk PE, Simoons ML.

Eur Heart J. 2010 Dec;31(24):3032-9. doi: 10.1093/eurheartj/ehq324. Epub 2010 Sep 9.

PMID:
20829210
29.

Second-generation optical coherence tomography in clinical practice. High-speed data acquisition is highly reproducible in patients undergoing percutaneous coronary intervention.

Gonzalo N, Tearney GJ, Serruys PW, van Soest G, Okamura T, García-García HM, Jan van Geuns R, van der Ent M, Ligthart J, Bouma BE, Regar E.

Rev Esp Cardiol. 2010 Aug;63(8):893-903. English, Spanish.

30.

First-in-man clinical use of combined near-infrared spectroscopy and intravascular ultrasound: a potential key to predict distal embolization and no-reflow?

Schultz CJ, Serruys PW, van der Ent M, Ligthart J, Mastik F, Garg S, Muller JE, Wilder MA, van de Steen AF, Regar E.

J Am Coll Cardiol. 2010 Jul 20;56(4):314. doi: 10.1016/j.jacc.2009.10.090. No abstract available.

31.

Randomized comparison of the magnetic navigation system vs. standard wires in the treatment of bifurcations.

Ramcharitar S, van der Giessen WJ, van der Ent M, Serruys PW, van Geuns RJ.

Eur Heart J. 2011 Jun;32(12):1479-83. doi: 10.1093/eurheartj/ehq123. Epub 2010 May 2.

PMID:
20439262
32.

First use in patients of a combined near infra-red spectroscopy and intra-vascular ultrasound catheter to identify composition and structure of coronary plaque.

Garg S, Serruys PW, van der Ent M, Schultz C, Mastik F, van Soest G, van der Steen AF, Wilder MA, Muller JE, Regar E.

EuroIntervention. 2010 Jan;5(6):755-6. No abstract available.

PMID:
20142232
33.

Crossing of a calcified "balloon uncrossable" coronary chronic total occlusion facilitated by a laser catheter: a case report and review recent four years' experience at the Thoraxcenter.

Shen ZJ, García-García HM, Schultz C, van der Ent M, Serruys PW.

Int J Cardiol. 2010 Nov 19;145(2):251-254. doi: 10.1016/j.ijcard.2009.08.028. Epub 2009 Sep 13. Review.

PMID:
19751952
34.

Mechanical circulatory support devices improve tissue perfusion in patients with end-stage heart failure or cardiogenic shock.

den Uil CA, Maat AP, Lagrand WK, van der Ent M, Jewbali LS, van Thiel RJ, Spronk PE, Simoons ML.

J Heart Lung Transplant. 2009 Sep;28(9):906-11. doi: 10.1016/j.healun.2009.05.010.

PMID:
19716043
35.

Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure.

den Uil CA, Caliskan K, Lagrand WK, van der Ent M, Jewbali LS, van Kuijk JP, Spronk PE, Simoons ML.

Intensive Care Med. 2009 Nov;35(11):1893-9. doi: 10.1007/s00134-009-1591-4. Epub 2009 Jul 29.

PMID:
19639300
36.

Evaluation of a single-tube real-time PCR for detection and identification of 11 dermatophyte species in clinical material.

Bergmans AM, van der Ent M, Klaassen A, Böhm N, Andriesse GI, Wintermans RG.

Clin Microbiol Infect. 2010 Jun;16(6):704-10. doi: 10.1111/j.1469-0691.2009.02991.x. Epub 2009 Jul 20.

37.

Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.

Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, van Domburg RT, Serruys PW.

Eur Heart J. 2009 Sep;30(17):2102-8. doi: 10.1093/eurheartj/ehp292. Epub 2009 Jul 18. Review.

PMID:
19617601
38.

Usefulness of intra-aortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction.

Cheng JM, Valk SD, den Uil CA, van der Ent M, Lagrand WK, van de Sande M, van Domburg RT, Simoons ML.

Am J Cardiol. 2009 Aug 1;104(3):327-32. doi: 10.1016/j.amjcard.2009.03.050. Epub 2009 Jun 6.

PMID:
19616662
39.

Pre-procedural dual source 64-slice computed tomography in unprotected left main intervention.

Weustink AC, Schinkel AF, van der Ent M, de Feyter PJ.

JACC Cardiovasc Interv. 2009 May;2(5):470-1. doi: 10.1016/j.jcin.2008.12.016. No abstract available.

40.

Optical coherence tomography to guide treatment of chronic occlusions?

Schultz C, van der Ent M, Serruys PW, Regar E.

JACC Cardiovasc Interv. 2009 Apr;2(4):366-7. doi: 10.1016/j.jcin.2008.09.016. No abstract available.

41.

Computed tomography in total coronary occlusions (CTTO registry): radiation exposure and predictors of successful percutaneous intervention.

García-García HM, van Mieghem CA, Gonzalo N, Meijboom WB, Weustink AC, Onuma Y, Mollet NR, Schultz CJ, Meliga E, van der Ent M, Sianos G, Goedhart D, den Boer A, de Feyter P, Serruys PW.

EuroIntervention. 2009 Mar;4(5):607-16.

PMID:
19378681
42.

The effects of intra-aortic balloon pump support on macrocirculation and tissue microcirculation in patients with cardiogenic shock.

den Uil CA, Lagrand WK, van der Ent M, Jewbali LS, Brugts JJ, Spronk PE, Simoons ML.

Cardiology. 2009;114(1):42-6. doi: 10.1159/000212060. Epub 2009 Apr 9.

PMID:
19365113
43.

Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure.

den Uil CA, Lagrand WK, Spronk PE, van der Ent M, Jewbali LS, Brugts JJ, Ince C, Simoons ML.

Eur J Heart Fail. 2009 Apr;11(4):386-90. doi: 10.1093/eurjhf/hfp021. Epub 2009 Feb 10.

44.

Percutaneous coronary intervention for chronic total occlusions: value of preprocedural multislice CT guidance.

Van Mieghem CA, van der Ent M, de Feyter PJ.

BMJ Case Rep. 2009;2009:bcr2006105031. doi: 10.1136/bcr.2006.105031. Epub 2009 Feb 18. No abstract available.

45.

Reliable assessment of sedation level in routine clinical practice by adding an instruction to the Ramsay Scale.

van Dishoeck AM, van der Hooft T, Simoons ML, van der Ent M, Scholte op Reimer WJ.

Eur J Cardiovasc Nurs. 2009 Jun;8(2):125-8. doi: 10.1016/j.ejcnurse.2008.10.004. Epub 2008 Dec 3.

PMID:
19056319
46.

A randomized comparison of the magnetic navigation system versus conventional percutaneous coronary intervention.

Ramcharitar S, van Geuns RJ, Patterson M, van der Giessen WJ, van der Ent M, van Domburg RT, Serruys PW.

Catheter Cardiovasc Interv. 2008 Nov 15;72(6):761-70. doi: 10.1002/ccd.21674.

PMID:
18798236
47.

Validation of PCR-reverse line blot, a method for rapid detection and identification of nine dermatophyte species in nail, skin and hair samples.

Bergmans AM, Schouls LM, van der Ent M, Klaassen A, Böhm N, Wintermans RG.

Clin Microbiol Infect. 2008 Aug;14(8):778-88. doi: 10.1111/j.1469-0691.2008.02036.x.

48.

Impaired sublingual microvascular perfusion during surgery with cardiopulmonary bypass: a pilot study.

den Uil CA, Lagrand WK, Spronk PE, van Domburg RT, Hofland J, Lüthen C, Brugts JJ, van der Ent M, Simoons ML.

J Thorac Cardiovasc Surg. 2008 Jul;136(1):129-34. doi: 10.1016/j.jtcvs.2007.10.046. Epub 2008 May 2.

49.

Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital-(RESEARCH) registry.

García-García HM, Daemen J, Kukreja N, Tanimoto S, van Mieghem CA, van der Ent M, van Domburg RT, Serruys PW.

Catheter Cardiovasc Interv. 2007 Nov 1;70(5):635-9.

PMID:
17960629
50.

Percutaneous coronary intervention for chronic total occlusions: value of preprocedural multislice CT guidance.

Van Mieghem CA, van der Ent M, de Feyter PJ.

Heart. 2007 Nov;93(11):1492. No abstract available.

Supplemental Content

Loading ...
Support Center